Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer.
Guglielmo ManentiMarco NezzoColleen Patricia RyanFederico Romeo FraioliBeatrice CarreriPaola Elda GigliottiCecilia AngeloniFrancesca Di PietroMartina De AngeliTommaso PerrettaRolando Maria D'AngelilloFrancesco Giuseppe GaraciPublished in: BJR open (2023)
Our study investigated TPLA as a salvage treatment for low-risk recurrent prostate cancer after RT, demonstrating its tolerability, feasibility, and effectiveness.